DB05753InvestigationalSmall molecule
VSF-173 is an oral small molecule. It is an oral compound that has demonstrated effects on animal sleep/wake patterns and gene expression patterns suggestive of a stimulant effect. It is... It is developed for the treatment of excessive sleepiness.
- Primary indication
- Investigated for use/treatment in sleep disorders.Curator reviewed
- Code names
- VSF-173
What you can answer from here — as of April 02, 2025
Which companies are running trials of VSF-173, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account